Artem Oganesyan: A Promising Step Forward in the Field of Supportive Care and Oral Mucositis
Artem Oganesyan, Resident Physician at Jefferson Health, shared a post on LinkedIn, about a recent article he and his colleagues co-authored, adding:
“Our SPOM trial results are finally published. We showed that a simple device can be of potential use and help in prevention strategies for such a serious complication, as oral mucositis, in patients undergoing chemotherapy.
This can be a promising step forward in the field of Supportive Care and Oral Mucositis.
My sincere gratitude goes to our wonderful team (Lucy Harutyunyan, Maria Badikyan, Araksya Vanoyan, Nare Martirosyan) for their perseverance and hard work. This publication would not have been possible without you!
And of course, thanks to Yervand Hakobyan and Eli D Ehrenpreis for co-leading this project!
This work is a result of a years-long collaboration that happened despite all the challenges.”
Title: Tolerability and safety of a new oral device for prevention and treatment of oral mucositis in patients with hematologic malignancies undergoing chemotherapy
Authors: Artem Oganesyan, Lusine Harutyunyan, Araksya Vanoyan, Nare Martirosyan, Maria Badikyan, Mark Gregory, Tigran Oganesyan, Nerses Ghahramanyan, Eli D. Ehrenpreis, Yervand Hakobyan
Read the Full Article on Springer Nature Link
More posts featuring Artem Oganesyan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023